6th Microbiome Movement - Drug Development Summit Europe
Evvnt Promotion / evvnt
Archivo
25.01.2022 - 27.01.2022 Online, United Kingdom
Time: 10:00 AM - 5:50 PM
Temas de la conferencia
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Información e inscripción:
https://go.evvnt.com/919896-2?pid=4832
Ms. Emily Lincoln
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
